United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0143-9890_7dd1fe92-e406-4dde-a0e7-abfc496ccfc3
- Product NDC
- 0143-9890
- Form
- INJECTION
- Composition / generic term
- Ondansetron
- Labeler
- West-Ward Pharmaceuticals Corp
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20061226
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 20 mL in 1 VIAL, MULTI-DOSE (0143-9890-01) · 0143-9890-01
- 10 VIAL, MULTI-DOSE in 1 CARTON (0143-9890-10) / 20 mL in 1 VIAL, MULTI-DOSE (0143-9890-01) · 0143-9890-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →